Portfolio leadership Connecticut Innovations is the leading strategic venture capital arm in Connecticut with a track record of high portfolio exit value in New England, suggesting strong deal flow, active exits, and meaningful potential for strategic co-investments and partnership opportunities with growth-stage tech companies.

Active investments Recent funding activity includes investments in AdaptiveInsurance, Neurosoft Bioelectronics, CREW Carbon, and Mission BioCapital collaborations, indicating CI’s ongoing appetite for fintech, neurotech, climate/biotech, and enterprise software spaces—a signal for targeting recurring funding rounds and co‑investment conversations.

Strategic partnerships CI frequently partners with universities, accelerators, and major corporate and venture players, creating opportunities to position your solution as a strategic enablement for portfolio companies through introductions, pilots, and potential co‑development or deployment partnerships.

Tech enablement CI’s technology stack includes AI tools and analytics platforms (OpenAI, HubSpot Analytics, Adobe Experience Cloud, Shopify) which suggests openness to modern software solutions, marketing automation, data analytics, and customer experience enhancements that can be offered to portfolio companies.

Scale and exit focus With recognition as No. 1 in New England for portfolio exit value and a revenue range of 50 to 100 million, CI represents a favorable partner for late‑stage growth, strategic exits, and advisory or governance roles for firms aiming to accelerate toward lucrative liquidity events.